These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4902019)

  • 41. Use of propranolol to control rate-pressure product during cardiac anesthesia.
    Safwat AM; Reitan JA; Misle GR; Hurley EJ
    Anesth Analg; 1981 Oct; 60(10):732-5. PubMed ID: 7027826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of hyperkinetic heart syndrome with alinidine and propranolol].
    Schräder R; Degoutrie G; Landgraf H; Kaltenbach M
    Klin Wochenschr; 1987 Jan; 65(2):69-75. PubMed ID: 3560788
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Responsibility of the adrenergic sympathetic system in the hyperkinetic cardiovascular syndrome of hyperthyroidism. Study with adrenergic anatagonists].
    Barbaresi F; Pavarani A; Starcich R
    G Clin Med; 1967 Dec; 48(12):1280-301. PubMed ID: 5617381
    [No Abstract]   [Full Text] [Related]  

  • 44. Hemodynamic effects of lidocaine.
    Cullhed I
    Isr J Med Sci; 1969; 5(4):750-3. PubMed ID: 5820510
    [No Abstract]   [Full Text] [Related]  

  • 45. [On the action of propranolol on the phases of cardiac dynamics in normal, myocardiosclerotic and hypersympathicotonic subjects].
    Lixi M; Camoglio E; Sassu P; Biddau C; Porrazzo G; Raffo M; Cherchi A
    Boll Soc Ital Cardiol; 1966; 11(4):1510-22. PubMed ID: 5992067
    [No Abstract]   [Full Text] [Related]  

  • 46. [Effect of beta adrenergic blockade on the cardiovascular system in the state of sympathicotonia in children].
    Baszczyński J
    Pediatr Pol; 1968; 44(1):47-52. PubMed ID: 5728842
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinic and therapy of the hyperdynamic heart syndrome.
    Kuemmerle HP; Fitzgerald JD
    Int Z Klin Pharmakol Ther Toxikol; 1968 Apr; 1(4):296-301. PubMed ID: 5702005
    [No Abstract]   [Full Text] [Related]  

  • 48. [Severe neurosis with tachycardia treated by propranolol. Functional respiratory and cardiac hemodynamic study].
    Tourniaire A; Tartulier M; Blum J; Deyrieux F
    Presse Med (1893); 1968 Feb; 76(8):385-6. PubMed ID: 5645007
    [No Abstract]   [Full Text] [Related]  

  • 49. [Approaches to the diagnosis or the vegetovascular dystonia syndrome in children].
    Belokon' NA; Shvarkov SB; Osokina GG; Belozerov IuM; Shkol'nikova MA
    Pediatriia; 1986 Jan; (1):37-41. PubMed ID: 3951943
    [No Abstract]   [Full Text] [Related]  

  • 50. Synchronous recordings of Bcg, ECG, carotid pulse wave, and PCG in acute pharmacological trials.
    Lydtin H; Schnelle K; Lohmöller G; Zöllner N
    Bibl Cardiol; 1969; 26():36-41. PubMed ID: 5402368
    [No Abstract]   [Full Text] [Related]  

  • 51. [Gilutensin-Heptaminol in vegetative circulatory regulation disorders].
    Aschke J; Trieb G; Nusser E
    Med Klin; 1970 Oct; 65(43):1878-83. PubMed ID: 5476058
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effects of impulse magnet field and beta adrenergic blockaders on physical work capacity and hemodynamics of patients with neurocirculatory dystonia of the cardiac type].
    Orlov LL; Makoeva LD; Glezer MG; Memetov KA; Belinskaia TF; Arzhanenko OM
    Kardiologiia; 1991 Feb; 31(2):36-9. PubMed ID: 2041288
    [No Abstract]   [Full Text] [Related]  

  • 53. Propranolol in the therapy of ischaemic heart disease with angina pectoris.
    Banerjea JC; Mukherjee SK; Mukherjee TP
    Indian Heart J; 1969 Jul; 21(3):259-72. PubMed ID: 4904075
    [No Abstract]   [Full Text] [Related]  

  • 54. [Heart and circulatory dynamics of the dog under the effect of the beta-receptor blocking agent propranolol].
    Gersmeyer EF; Beyer E; Leicht E; Spitzbarth H
    Z Gesamte Exp Med Einschl Exp Chir; 1967; 143(1):85-96. PubMed ID: 4871304
    [No Abstract]   [Full Text] [Related]  

  • 55. [Pharmacologic effect of a beta-receptor blocking agent (LB-46) on hemodynamics].
    Köhler M
    Z Kreislaufforsch; 1970 Aug; 59(8):708-19. PubMed ID: 5513291
    [No Abstract]   [Full Text] [Related]  

  • 56. The treatment of functional heart disorders with beta-adrenergic blocking agents.
    Imhof P; Brunner H
    Postgrad Med J; 1970 Nov; ():Suppl:96-9. PubMed ID: 4395467
    [No Abstract]   [Full Text] [Related]  

  • 57. Hemodynamic effects of experimental hypercitremia.
    Corbascio AN; Smith NT
    Anesthesiology; 1967; 28(3):510-6. PubMed ID: 6023523
    [No Abstract]   [Full Text] [Related]  

  • 58. [Indications for beta-blockers in other cardiac diseases: rhythm disorders, obstructive cardiomyopathy, cardiothyreosis and neurocirculatory asthenia].
    Guize L; Le Heuzey JY
    Rev Prat; 1984 Apr; 34(19):967-72. PubMed ID: 6144163
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effects of propranolol on blood circulation in hyperthyreosis].
    Thimme W; Buschmann HJ; Dissmann W; Pust R; Ramdohr B
    Z Kreislaufforsch; 1971 Oct; 60(10):900-10. PubMed ID: 5124250
    [No Abstract]   [Full Text] [Related]  

  • 60. [Influence of a beta-blocking drug on the effects of a psychologic stress. I. Arterial pressure, heart rate, E.C.G].
    Mathis I; Accatino G
    Boll Soc Ital Biol Sper; 1970 Apr; 46(8):405-10. PubMed ID: 4926364
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.